Study to Gather Information About the Actual Use of an Adhesive Patch Placed on the Skin to Deliver Oxytrol Through the Skin Into the Bloodstream.
Completed
Bayer
Phase 3
2010-05-25
With this study researchers want to gather information about the consumer use behavior of
Oxytrol in a simulated setting in which the medicine is sold directly to a consumer without a
prescription from a healthcare professional. An area of focus was on the potential benefits
of an over-the-counter status for Oxytrol and on the ongoing use behavior of the consumers.
Oxytrol is a thin, flexible, clear patch that is indicated for the treatment of overactive
bladder a disease characterized by a collection of symptoms, including urinary frequency,
urgency, and urge incontinence. The adhesive patch is placed on the skin to deliver Oxytrol
through the skin into the bloodstream.
Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition
Completed
Watson Pharmaceuticals
Phase 4
2004-12-01
This study will evaluate the safety and effectiveness of an anticholinergic drug treatment
administered by transdermal patch to treat overactive bladder in children who have a
neurological condition (e.g. spina bifida) that contributes to their overactive bladder.
A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition
Completed
Watson Pharmaceuticals
Phase 4
2004-12-01
This study will evaluate the efficacy and safety of an anticholinergic drug treatment
administered by transdermal patch to treat overactive bladder in adults who have spinal cord
injury.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
